跳至主要内容
临床试验/NCT00661596
NCT00661596已完成3 期

Multi-centre, Randomised, Double-blind, Parallel, Placebo-controlled Clinical Study to Assess the Efficacy of Vardenafil and Its Influence on Self-esteem and Self-confidence in Patients With Erectile Dysfunction

Bayer0 个研究点目标入组 129 人开始时间: 2003年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Bayer
入组人数
129
主要终点
International Index of Erectile Function - Erectile Function Domain

研究概览

简要总结

Erectile problems may lead to anxiety, loss of self-esteem and depression and/or stress. The purpose of this national study was to determine if vardenafil is effective in treating impotent men (erectile dysfunction) and evaluate its influence in self-esteem and self-confidence. During the visits the patients was asked some questions about erections, and he fill different questionnaires about sexuality, mood, feelings, self-esteem and sexual activity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age: 18 years and older
  • Males with erectile dysfunction
  • Stable heterosexual relationship

排除标准

  • Primary hypoactive sexual desire- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months
  • Nitrate use
  • Other exclusion criteria apply acc. to Summary of Product Characteristics

研究组 & 干预措施

Arm 1

Experimental

干预措施: Levitra (Vardenafil, BAY38-9456) (Drug)

Arm 2

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

International Index of Erectile Function - Erectile Function Domain

时间窗: 12 weeks

次要结局

  • Other diary based variables(12 weeks)
  • Safety and tolerability(12 weeks)
  • Global Assessment Questionnaire(12 weeks)
  • IIEF-EF domain score(12 weeks)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验